The E3L Gene of Vaccinia Virus Encodes an Inhibitor of the Interferon-induced, Double-stranded RNA-dependent Protein Kinase

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Jun 1

PMID 1350676

Citations 248

Authors

H W Chang

J C Watson

B L Jacobs

Affiliations

Soon will be listed here.

Abstract

A vaccinia virus-encoded double-stranded RNA-binding protein, p25, has been previously implicated in inhibition of the interferon-induced, double-stranded RNA-activated protein kinase. In this study, we have identified the vaccinia viral gene (WR strain) that encodes p25. Amino acid sequence analysis of a chymotryptic fragment of p25 revealed a close match to the vaccinia virus (Copenhagen strain) E3L gene. The WR strain E3L gene was cloned and expressed either in COS-1 cells or in rabbit reticulocyte lysates in vitro. A M(r) 25,000 polypeptide that could bind to poly(rI).poly(rC)-agarose and that reacted with p25-specific antiserum was produced in each case. In addition, COS cells expressing E3L gene products inhibited activation of the double-stranded RNA-activated protein kinase in extracts from interferon-treated cells. Removal of E3L-encoded products by adsorption with anti-p25 antiserum resulted in loss of kinase inhibitory activity. These results demonstrate that the vaccinia virus E3L gene encodes p25 and that the products of the E3L gene have kinase inhibitory activity. Comparison of the deduced amino acid sequence of the E3L gene products with the protein sequence data base revealed a region closely related to the human interferon-induced, double-stranded RNA-activated protein kinase.

Citing Articles

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance.

Witwit H, Cubitt B, Khafaji R, Castro E, Goicoechea M, Lorenzo M Viruses. 2025; 17(1).

PMID: 39861882 PMC: 11769280. DOI: 10.3390/v17010092.

Host species-specific activity of the poxvirus PKR inhibitors E3 and K3 mediate host range function.

Haller S, Park C, Bruneau R, Megawati D, Zhang C, Vipat S J Virol. 2024; 98(11):e0133124.

PMID: 39480085 PMC: 11575334. DOI: 10.1128/jvi.01331-24.

Modifications of Mitochondrial Network Morphology Affect the MAVS-Dependent Immune Response in L929 Murine Fibroblasts during Ectromelia Virus Infection.

Gregorczyk-Zboroch K, Szulc-Dabrowska L, Pruchniak P, Gierynska M, Mielcarska M, Biernacka Z Pathogens. 2024; 13(9).

PMID: 39338909 PMC: 11434706. DOI: 10.3390/pathogens13090717.

The monkeypox virus-host interplays.

Yi X, Lei Y, Li M, Zhong L, Li S Cell Insight. 2024; 3(5):100185.

PMID: 39144256 PMC: 11321328. DOI: 10.1016/j.cellin.2024.100185.

Type I Interferon: Monkeypox/Mpox Viruses Achilles Heel?.

Williams J, Bonner J, Kibler K, Jacobs B Adv Exp Med Biol. 2024; 1451:125-137.

PMID: 38801575 DOI: 10.1007/978-3-031-57165-7_8.

References

NASHIMOTO H, Uchida H . DNA sequencing of the Escherichia coli ribonuclease III gene and its mutations. Mol Gen Genet. 1985; 201(1):25-9. DOI: 10.1007/BF00397981. View

Kitajewski J, Schneider R, Safer B, Shenk T . An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines. Mol Cell Biol. 1986; 6(12):4493-8. PMC: 367233. DOI: 10.1128/mcb.6.12.4493-4498.1986. View

Field A, TYTELL A, Lampson G, HILLEMAN M . Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967; 58(3):1004-10. PMC: 335739. DOI: 10.1073/pnas.58.3.1004. View

Isle H, Venkatesan S, Moss B . Cell-free translation of early and late mRNAs selected by hybridization to cloned DNA fragments derived from the left 14 million to 72 million daltons of the vaccinia virus genome. Virology. 1981; 112(1):306-17. DOI: 10.1016/0042-6822(81)90636-x. View

Whitaker-Dowling P, Youngner J . Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity. Virology. 1983; 131(1):128-36. DOI: 10.1016/0042-6822(83)90539-1. View

Paez E, Esteban M . Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology. 1984; 134(1):12-28. DOI: 10.1016/0042-6822(84)90268-x. View

Paez E, Esteban M . Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2'p)nA-synthetase. Virology. 1984; 134(1):29-39. DOI: 10.1016/0042-6822(84)90269-1. View

Whitaker-Dowling P, Youngner J . Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase. Virology. 1984; 137(1):171-81. DOI: 10.1016/0042-6822(84)90020-5. View

Safer B . 2B or not 2B: regulation of the catalytic utilization of eIF-2. Cell. 1983; 33(1):7-8. DOI: 10.1016/0092-8674(83)90326-4. View

10.

Rice A, Kerr I . Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells. J Virol. 1984; 50(1):229-36. PMC: 255603. DOI: 10.1128/JVI.50.1.229-236.1984. View

11.

Cleveland D, Fischer S, Kirschner M, Laemmli U . Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977; 252(3):1102-6. View

12.

Davies M, Elroy-Stein O, Jagus R, Moss B, Kaufman R . The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol. 1992; 66(4):1943-50. PMC: 288982. DOI: 10.1128/JVI.66.4.1943-1950.1992. View

13.

Watson J, Chang H, Jacobs B . Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology. 1991; 185(1):206-16. DOI: 10.1016/0042-6822(91)90768-7. View

14.

Meurs E, Chong K, Galabru J, Thomas N, Kerr I, Williams B . Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 1990; 62(2):379-90. DOI: 10.1016/0092-8674(90)90374-n. View

15.

Lee T, Tomita J, Hovanessian A, Katze M . Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci U S A. 1990; 87(16):6208-12. PMC: 54502. DOI: 10.1073/pnas.87.16.6208. View

16.

Beattie E, Tartaglia J, Paoletti E . Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology. 1991; 183(1):419-22. DOI: 10.1016/0042-6822(91)90158-8. View

17.

Jacobs B, Ferguson R . The Lang strain of reovirus serotype 1 and the Dearing strain of reovirus serotype 3 differ in their sensitivities to beta interferon. J Virol. 1991; 65(9):5102-4. PMC: 248978. DOI: 10.1128/JVI.65.9.5102-5104.1991. View

18.

Goebel S, Johnson G, Perkus M, Davis S, Winslow J, Paoletti E . The complete DNA sequence of vaccinia virus. Virology. 1990; 179(1):247-66, 517-63. DOI: 10.1016/0042-6822(90)90294-2. View

19.

Whitaker-Dowling P, Youngner J . Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon. Virology. 1986; 152(1):50-7. DOI: 10.1016/0042-6822(86)90370-3. View

20.

Samuel C, Knutson G, Berry M, Atwater J, Lasky S . Purification of double-stranded RNA-dependent protein kinase from mouse fibroblasts. Methods Enzymol. 1986; 119:499-516. DOI: 10.1016/0076-6879(86)19070-7. View